Pro Medicus subsidiary launches diagnostic imaging product for Apple Vision Pro

Australian health imaging company Pro Medicus (ASX: PME) has announced its wholly-owned US subsidiary Visage Imaging will launch Visage Ease VP for Apple’s mixed-reality Vision Pro headset.

Visage Ease VP will support immersive and spatial experiences for diagnostic imaging and multimedia using Apple’s technology.

It will include the proven functionality of the earlier release Visage Ease, with the addition of a powerful cinematic engine to enable volume-rendered images at more than 4K resolution.

Visage Ease VP will employ the natural and intuitive input of eyes, hands and voice navigation to provide end users with an imaging experience “unlike any other application” on the market.

It is the latest member of the Visage Ease family of native applications purpose-built for the Apple ecosystem, joining Visage Ease (for iOS/iPadOS) and Visage Ease Pro (iPadOS).

Visage Imaging also offers the Visage 7 smart-client application for macOS, providing native, ultra-fast and clinically-rich access to enterprise imaging.

Visage Ease VP is designed for use on the Visage 7 enterprise imaging platform.

New era of imaging

Visage Imaging co-founder and global chief technology officer Malte Westerhoff said the launch of Visage Ease VP ushers in a new era of spatial imaging and workflow possibilities.

“Visage’s platform of enterprise imaging applications, which support the Apple ecosystem, are used by many of the world’s largest and most sophisticated healthcare organisations and are integrated bi-directionally to the most widely-used electronic health records,” he said.

“Visage Ease VP allows us to extend our offering to immersive spatial imaging, which has the potential to open up a number of novel and exciting possibilities within the medical imaging and wider healthcare space.”

First customer

Tier 1 academic medical centre UC San Diego Health is expected to be the first Visage customer to pilot the technology.

“The visualisation of three-dimensional medical imaging in immersive space creates exciting opportunities to improve patient care,” said the centre’s associate professor and radiologist Dr Paul Murphy.

“Technology, which allows for sophisticated eye motion and gesture controls for reviewing 2D and 3D medical imaging, could potentially help in efficient tumour board reviews and create collaborative spaces in healthcare.”